Use of and retention on video, telephone, and in-person buprenorphine treatment for opioid use disorder during the COVID-19 pandemic

MC Frost, L Zhang, HM Kim, LA Lin - JAMA Network Open, 2022 - jamanetwork.com
Importance The coronavirus disease 2019 (COVID-19) pandemic prompted policy changes
to allow increased telehealth delivery of buprenorphine, a potentially lifesaving medication …

Telemedicine-delivered treatment for substance use disorder: A scoping review

H Pham, C Lin, Y Zhu, SE Clingan… - Journal of …, 2023 - journals.sagepub.com
Introduction The COVID pandemic prompted a significant increase in the utilization of
telemedicine (TM) for substance use disorder (SUD) treatment. As we transition towards a …

Key implementation factors in telemedicine-delivered medications for opioid use disorder: a scoping review informed by normalisation process theory

JTW Teck, G Zlatkute, A Perez, H Dritschel… - The Lancet …, 2023 - thelancet.com
Telemedicine could improve access to medications for opioid use disorder (MOUD).
Telemedicine-delivered MOUD (TMOUD) has expanded substantially in response to the …

[HTML][HTML] “You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic

A Conway, C Treloar, S Crawford, L Degenhardt… - International Journal of …, 2023 - Elsevier
Background Opioid agonist treatment (OAT) improves multiple health and social outcomes,
yet requirements to attend for supervised dosing can be burdensome and stigmatising. The …

Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy implications for expanding opioid use disorder care in the United …

N Krawczyk, BD Rivera, C King… - Health Affairs …, 2023 - academic.oup.com
Buprenorphine is a highly effective treatment for opioid use disorder (OUD) and a critical tool
for addressing the worsening US overdose crisis. However, multiple barriers to treatment …

Understanding the use of telemedicine across different opioid use disorder treatment models: A scoping review

J Tay Wee Teck, JL Butner… - … of Telemedicine and …, 2023 - journals.sagepub.com
Introduction The COVID-19 pandemic has instigated the development of telemedicine-
mediated provision of medications for opioid use disorder such as buprenorphine and …

Use of telehealth for opioid use disorder treatment in safety net primary care settings: A mixed-methods study

SR Bailey, T Wyte-Lake, JA Lucas… - Substance use & …, 2023 - Taylor & Francis
Background: The COVID-19 pandemic resulted in a marked increase in telehealth for the
provision of primary care-based opioid use disorder (OUD) treatment. This mixed methods …

[HTML][HTML] Digital geographies of care: Telehealth landscapes of addiction treatment during the COVID-19 pandemic

A Rishworth, B King, LM Holmes - Health & Place, 2024 - Elsevier
The COVID-19 pandemic has created new digital health care landscapes for the
management of substance use and misuse. While telehealth was prohibited for addiction …

Clinician perspectives on delivering medication treatment for opioid use disorder during the COVID-19 pandemic: a qualitative evaluation

AM Lott, AN Danner, CA Malte… - Journal of addiction …, 2023 - journals.lww.com
Objective The coronavirus disease 2019 (COVID-19) pandemic necessitated changes in
opioid use disorder care. Little is known about COVID-19's impact on general healthcare …

[HTML][HTML] Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009–2018

MS Schuler, AW Dick, AJ Gordon, B Saloner… - Drug and alcohol …, 2024 - Elsevier
Background We examined the number and characteristics of high-volume buprenorphine
prescribers and the nature of their buprenorphine prescribing from 2009 to 2018. Methods In …